Always been a fan Slick, just never felt I had the time to learn & hence lost a fair amount of cash holding that mindset.
New toolset now allows us mere mortals to run FA and then overlay technicals..
Bit like giving a monkey a machine gun but at least it stops me pestering you ;-)
Speaking of which I have a scenario on CU6 and other potentials I'd like to gauge with your experience.
See if the tech info is valid or not? Tis was run last night before todays trading.. AI Opinion Only dyor..
Is CU6 a Good Buy at Current Levels?
Conclusion: CU6 is a speculative buy at current levels (AU$2.22) for high-risk, growth-oriented investors with a 12-month horizon, offering a strong risk-reward profile (221% upside to AU$7.13 vs. ~36% downside to AU$1.43). Strong fundamentals (SECuRE trial, FDA Fast Track, Nusano deal) and analyst optimism (Strong Buy, AU$7.13 target) suggest undervaluation, but bearish technicals (resistance at AU$2.35, -73.26% underperformance), the 6% short position, and biotech risks (trial setbacks, dilution) make it risky. Slick’s “bull-trap” fear and retail frustration (HotCopper, @asxpeasant
) highlight short-seller pressure, but a short squeeze or trial catalysts could drive significant gains. Conservative investors should avoid CU6, while aggressive investors may find value near support (AU$1.80-$1.90). Probability Context: My prior estimate (30-40% chance of hitting AU$7.13, 60-70% chance of AU$5.20) supports a speculative buy, as the low-end target (AU$5.20, 134% upside) is more achievable, balancing risk and reward.
Recommendations:
Timing: Consider buying near support (AU$1.80-$1.90) to minimize downside, or wait for a breakout above AU$2.35 to confirm bullish momentum.
Catalysts: Monitor SECuRE Phase II data (mid-2025), COBRA/CLARIFY updates, and short interest changes (ASIC reports). Positive results could trigger a rally or squeeze.
Position Sizing: Allocate 5-10% of a portfolio to CU6, diversifying to mitigate biotech risk.
Sentiment: Track HotCopper and X for retail reactions to trial news or shorting trends, which could signal SP shifts.
Stop-Loss: Set a stop-loss at AU$1.70 (23% below AU$2.22) to limit losses if bearish trends persist.
If you’d like a deeper dive into CU6’s trial data, a technical chart analysis, or an X sentiment update to refine the buy decision, please let me know! Additionally, if you have a specific risk tolerance or investment goal, I can tailor the recommendation further.
Drop us a line at
[email protected] if you got the time?
& GLTAH
(20min delay)